EA2185
OPEN TO ACCRUAL
Pancreatic Cyst Surveillance
EA2192
OPEN TO ACCRUAL
APOLLO: PII Adjuvant Olaparib vs Placebo for Resected Pancreatic Cancer with BRCA1/2 or PALB2
NCI10366
OPEN TO ACCRUAL
A Phase 1/Randomized Phase 2 Study of M3814 w/ Hypofractionated Radiotherapy for LAPC
NCI10464
OPEN TO ACCRUAL
Ph1 Olaparib in Combo with durvalumab & radiation following 1st line chemo locally adv unresec panc
UW24025
OPEN TO ACCRUAL
A Phase II Multicenter Trial of ESK981 in Patients With Select Solid Tumors
UW25051
OPEN TO ACCRUAL
P1b/2 study of GSK5764227 in previously treated advanced unresectable or metastatic GI solid tumors